Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Someone filling up big time
I bought these after their positive news late October as they started rising. Have noticed it's time to buy more owing to I reckon they are a bargain price at 7p less than I paid in early Nov. Expect the rise upwards soon; they may also be mentioned in papers as a New Year Tip, so best to invest prior tomorrow ! Maybe !
The product showed positive results in all trials, including the stringent US one. The assumption is that the product in real world should emulate the trial percentages.
It would be extremely unlikely that trial results were all wrong and the product didn't work! ....and the accreditation were erroneously awarded.
At Worse, the percentages may be lower, however considering the ED market alone (Not including the recreation market) worldwide, the potential remains sizable. The SP today is nowhere near reflecting this.
On the positive side, if the product in real world were to reflect trial results, the potential would be exponential and SP would, at least meet the broker target.
It's all good!
Just a matter of time.
they spoke about £45m from haleon alone!
No accounts of sales in new places never mind the UK
Mr Barder mentioned on a proactive interview that there was NO NEED FOR ANY FINANCING
* a company making big income and growing income
* fully financed
Only a fool couldn't see the potential of this product.....
DRM72- we don’t know if they need to be creative with packs, offering smaller quantities as nobody knows what the sales figures are like! Due to the complete silence from the company! We will see in the next 3month and end of year financials in march!
I started 2023 by nominating this as my share for the year, fool that I am. All the signs were that things were finally going to come good. Launches across the world, actual sales accumulating, US launch. etc. All of these have happened and yet here we are at 26p . Who is baling out and who is hanging on, sure that 2024 will be the year when we spread the jam thickly? I remain optimistic but it is getting harder to maintain that confidence.
Thinks they need to be more creative with the packs and also more functional tubes (packs at single and doubles )
Also price pack of 4 iEroxon s more expensive than pack of 4 Cialis and Viagra and way more that boots brand (by £10)
people happy to spend a £5 single or £10 double not £25
Issue is one product is not a business, and FUM have currently put on hold all other developments which is also effecting the SP. IMO. Instead of the BOD paying themselves half a £mill each, they should have recruited staff and continued with the R&D. I think a lot of investor will be looking for an exit strategy because if LB start shifting shares they are in trouble.
Totally agree rpg. Amazon U.K. was showing c7k per month sales in July / August and now 1k. I know there are plenty of other retailers now but it’s flatlining. Things don’t sell without marketing unless they have amazing word of mouth or thousands of intermediaries (ie doctors) pushing them.
Think the Bod need to get off their best feature and issue some reassurance to investors regarding the share price movement. Shorters starting to come out of the woodwork.
A nasal spray? Awesome. Sniffy for a stiffy..
I emailed to ask when they were going to start giving a quarterly trading update - not unusual in retail. Answer was no. Twice yearly.
Will you be giving end of year update. No
Will you give end of year cash position just to reassure that all good for next 12 months. No
I’m not sure what to think…
Sounds like the most plausible explanation, yet another lesson for Barder, be cautious when you're doing business with the Chinese. They'll keep selling alright, they're probably in profit anyway and couldn't give a fook about tanking the share price. Also, there is an Australian company recruiting for trials of a new type of viagra. that is administered using a nasal spray.
Personally, I still think the China company are still seeling there 9 million shares...hence the constant drop. I was keeping a check on big sales and think we've still got another 2 million to go.
But this management are f'ing terrible to keeping sharesholders updated. Also, as mentioned by others it's in management interest to have the sharepirce drop as they will get more shares in "bonuses"....
It's time people started complaining to the management, has I have done many times. If you want to complain go here and fill in the online form
https://futuramedical.com/contact-us/
Everyone knows the reviews have been tainted by one or two bitter ex-investors. Boots are well aware of it, the number of reviews is off the scale. Didn't they award Eroxon "new product of the year" or something similar so they don't take the reviews for Eroxon seriously. All the same, the share performance has been abysmal and I thought the directors' recently awarding themselves free shares before they have shown solid sales figures really took the Mickey out of shareholders who have stuck with this. They better come up with some good numbers soon as there seems to be little support, patience running thin on my part anyway.
I think the reviews of eroxon on the Boots website speak for themselves. 75% rated as rubbish, 25% as top notch. It looks like the placebo affect playing out in real life rather than as part of a clinical trial.. as long as those 25% keep believing and keep having sex and spread the word to their placebo reactive mates then the the sky is the limit…
Yet nothing on their much jewel in the crown that is a US launch. Haleon are sitting on this, why??
Well had a reply from FUM:
“As we are sure you have seen, we gave a full update on our commercialisation plans for MED3000 in our latest financial results in September. Launches remain in line with September’s announcement and we will continue to share further information as soon as we are able to do so.”
Meaning they are expected a further 9 country launches within 6month of Septembers RNS.
Looks like some weak hands have exited the building ,a fairly large wally flock. Plenty of a/holes fell out on the floor.
I’m of the view that there may well be important developments,but the board have concluded that to make any announcements now will just get sold into and end up having no impact on the share price.
Just remember this : this will be the only ED treatment in the USA not needing a prescription,and before the FDA gave its approval Eroxon had to go through a 6 month efficacy trial.Plus the company has been granted a 30 year patent extension.
I think those selling out now will repent at leisure in the new year.
My thoughts are the BOD are like the current government during the pandemic, making it up as they go along with bad decisions along the way! The only positive is that LB are holding tight so must be getting updates we aren’t privy to. I expect news start of the new year after the BOD have got their low price share allocation for 2025’s remuneration package.
Looks like we is heading back to the 25p low again, surely not! :( cmon futura, throw the market some good news :)
Another 2 decent buys looks like 27p is the entry point for shrewd investors TIME WILL TELL
Dosanddont, viaga is now owned by another company, if i am right. And surfie... sir, please dont throw in the towel too. Diamond hands for life :)
Think finally it may break out its been a long wait but will happen